The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia.
Open accessAbstract
The impact of chronic prophylactic administration of trimethoprim-sulfamethoxazole (SXT) on the ecology and the antimicrobial susceptibilities of bloodstream pathogens in human immunodeficiency virus (HIV)-infected patients was studied using a retrospective chart review. Eighty-nine patients with advanced HIV infection developed 124 episodes of bacteremia with 156 pathogenic isolates. Staphylococcus aureus and Enterobacteriaceae tended to be less common among patients receiving SXT. Isolates from patients receiving SXT were likelier (75%) to be resistant to 20 microg of SXT/ml than those from patients not receiving SXT (33%) (P < 0.001).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study found that significantly more TMP-SMX–resistant organisms were isolated from HIV-infected patients who had received TMP-SMX than from patients who had not received TMP-SMX (7).”
From Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance (2004) · cites this paper as [7]
In the citing paper
“Indeed, an increased number of sulfa-resistant bacteria have been isolated in HIV patients, which coincides with the rise in TMP-SMX prophylaxis for PCP (6,7).”
From Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance (2004) · cites this paper as [7]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,210
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,665
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,774
Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis
Hughes, W. T., Kuhn, S., Chaudhary, S., Feldman, S., Verzosa, M. S., Aur, R. J. A., Pratt, C. B., & George, S. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712292972602 · Cited by 683
Hardy, W. D., Feinberg, J., Finkelstein, D. M., Power, M. E., He, W., Kaczka, C., Frame, P. T., Holmes, M., Waskin, H., Fass, R. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212243272604 · Cited by 346
Self-citationGurwith, M., BRUNTON, J. L., Lank, B. A., Harding, G. K. M., & Ronald, A. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90539-4 · Cited by 244
Changing Ecology of Bacterial Infections as Related to Antibacterial Therapy
Finland, M. (1970) · Journal of Infectious Diseases · doi:10.1093/infdis/122.5.419 · Cited by 227
Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., & Verhoef, J. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-555 · Cited by 209
Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
Martin, J. N., Rose, D. A., Hadley, W. K., Perdreau‐Remington, F., Lam, P. K., & Gerberding, J. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/315132 · Cited by 126
Changing Patterns of Susceptibility of Common Bacterial Pathogens to Antimicrobial Agents
Finland, M. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1009 · Cited by 108
Meyer, C. N., Skinhøj, P., & Prag, J. (1994) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549409008630 · Cited by 69
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole
Edge, M. D., & Rimland, D. (1996) · AIDS · doi:10.1097/00002030-199612000-00007 · Cited by 48
Pedersen, G., Schønheyder, H. C., Steffensen, F. H., & Sørensen, H. T. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.119 · Cited by 41
Tumbarello, M., Tacconelli, E., Donati, K. D. G., Leone, F., Morace, G., Cauda, R., & Ortona, L. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199812150-00008 · Cited by 35
Buskin, S. E., Newcomer, L. M., Koutsky, L. A., Hooton, T. M., Spach, D. H., & Hopkins, S. G. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199902010-00014 · Cited by 28
Manfredi, R., Costigliola, P., Ricchi, E., & Chiodo, F. (1993) · PubMed · Cited by 27
Bacteremia in persons with HIV infection.
Northfelt, D., & Polsky, B. (1991) · PubMed · Cited by 18
Bacteremia in HIV-Infected Patients: Short-Term Predictors of Mortality
Omeñaca, C., Turett, G. S., Yarrish, R. L., Astiz, M., Lin, R., Kislak, J. W., & Cadden, J. J. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199910010-00007 · Cited by 15
Bacteremic infections in the HIV-infected patient and recurrent bacteremia
Bouza, E., & Rodríguez‐Créixems, M. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00540.x · Cited by 7
Cited by
Wang, X.-L., Wan, K., & Zhou, C.-H. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.07.031 · Cited by 376
Blomberg, B., Manji, K. P., Urassa, W. K., Tamim, B. S., Mwakagile, D., Jureen, R., Msangi, V., Tellevik, M. G., Holberg‐Petersen, M., Harthug, S., et al. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-43 · Cited by 224
Global strategies to prevent bacterial pneumonia in adults with HIV disease
Feikin, D. R., Feldman, C. H., Schuchat, A., & Janoff, E. N. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01060-6 · Cited by 193
Shah, S. S. A., Rivera, G., & Ashfaq, M. H. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/13895575130107 · Cited by 191
Jordano, Q., Falcó, V., Almirante, B., Planes, A. M., del Valle, O., Ribera, E., Len, Ó., Pigrau, C., & Pahissa, A. (2004) · Clinical Infectious Diseases · doi:10.1086/420933 · Cited by 155
Metadata
- Authors
- Wininger, D. A., & Fass, R. J.
- Affiliations
- The Ohio State University (US)
- ORCID
- Wininger, David A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-02
- Volume
- 46
- Issue
- 2
- Pages
- 594-597
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC127034
- OpenAlex
- W2081292177
- Cited by
- 27
- References
- 20
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 2
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U01AI025924, AI 25924)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- trimethoprim-sulfamethoxazole, bacteremia, HIV infection, antibiotic prophylaxis, antimicrobial resistance, Staphylococcus aureus, Enterobacteriaceae
- MeSH terms
- Anti-Infective Agents, Anti-Bacterial Agents, Enterobacteriaceae, Female, Humans, Male, Microbial Sensitivity Tests, Staphylococcus aureus, HIV Infections, Trimethoprim, Sulfamethoxazole Drug Combination, Bacteremia, AIDS-Related Opportunistic Infections, Chemoprevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
